Company / Gross Margin
BioRestorative Therapies, Inc. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
93.4%
FY2025
5-year range
93.4% / 100.0%
FY2021-FY2025
Trend
-6.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 100.0% to 93.4% over the past 2 years.
Based on SEC 10-K filings.
93.4% in FY2025.
Declined from 100.0% to 93.4% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 6.6% year-over-year.
- Peak gross margin was recorded in FY2024.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 93.4% | -6.6% |
| FY2024 | 100.0% | +0.0% |
| FY2023 | 100.0% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | 99.7% | +70.7% |
| FY2016 | 58.4% | +20.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026